Progyny, INC Form 4 insider transactions

Progyny's Chief Operating Officer, Melissa B. Cummings, was granted 45,454 restricted stock units and 66,289 stock options as part of an annual merit award.

Progyny's EVP and General Counsel, Allison Swartz, reported receiving significant equity grants while also executing pre-planned sales of common stock.

Progyny's Chief Financial Officer, Mark S. Livingston, was granted restricted stock units and stock options as part of an annual merit award, alongside tax-related share dispositions.

Progyny CEO Peter Anevski was granted restricted stock units and stock options, while also disposing of shares for tax obligations.

Progyny's Executive Chairman, David J. Schlanger, disposed of 2,171 common shares at $25.68 each to cover tax obligations from restricted stock unit vesting.

Progyny CEO Peter Anevski disposed of 6,009 shares of common stock at $25.68 per share to cover tax obligations related to restricted stock unit vesting.

Progyny's President, Michael E. Sturmer, reported a disposition of 33,028 shares of common stock for tax withholding purposes.

Progyny's Chief Financial Officer, Mark S. Livingston, sold 459 shares of common stock for $25.5 per share under a pre-arranged 10b5-1 trading plan.

Progyny's Chief Financial Officer, Mark S. Livingston, reported the withholding of 479 shares of common stock for tax purposes following the vesting of restricted stock units.

Progyny President Michael E. Sturmer reported a future disposition of 7,977 common shares on December 4, 2025, to cover tax withholding from restricted stock unit vesting.

Progyny's EVP and General Counsel, Allison Swartz, reported the sale of 530 shares and the withholding of 408 shares for taxes on December 4, 2025, under a pre-arranged 10b5-1 trading plan.

Progyny's Chief Financial Officer, Mark S. Livingston, reported the sale of company common stock and shares withheld for taxes, both executed under a pre-arranged 10b5-1 trading plan.

Progyny's President, Michael E. Sturmer, disposed of 448 shares of common stock to cover tax obligations related to restricted stock unit vesting.

Progyny's EVP and General Counsel, Allison Swartz, reported the sale of 2,398 shares and the withholding of 1,352 shares for taxes, both on November 28, 2025.

Progyny, Inc.'s Chief Financial Officer, Mark S. Livingston, sold 21,303 shares of common stock for $25.5 per share as part of a pre-arranged Rule 10b5-1 trading plan.

Progyny director Norman C. Payson exercised 36,224 options at $1.45 and transferred 50,265 shares to a revocable trust, with no shares sold.

Progyny CEO Peter Anevski acquired 79,500 shares of common stock for $24.288 per share on November 13, 2025, to offset a tax withholding obligation.

Progyny's Executive Chairman, David J. Schlanger, reported the vesting of performance stock units and subsequent share transactions for tax withholding.

Progyny CEO Peter Anevski reported the vesting of 125,000 performance stock units and the subsequent settlement of shares, with a portion withheld for taxes.

Progyny's Executive Chairman, David J. Schlanger, disposed of 1,893 shares of common stock for tax withholding purposes.

Progyny CEO Peter Anevski disposed of 7,977 shares of common stock to cover tax withholding obligations related to restricted stock unit vesting.

Progyny's EVP and General Counsel, Allison Swartz, reported the sale of 599 common shares and the withholding of 339 shares for taxes, both executed on September 4, 2025, under a pre-arranged 10b5-1 trading plan.

Progyny President Michael E. Sturmer disposed of 7,977 shares of common stock for tax withholding purposes related to restricted stock unit vesting.

Progyny's CFO, Mark S. Livingston, disposed of 479 shares of common stock to cover tax withholdings related to restricted stock unit vesting.

Progyny's President, Michael E. Sturmer, disposed of 448 shares of common stock for tax withholding purposes at a price of $23.67 per share.

Progyny's Chief Financial Officer, Mark S. Livingston, reported the withholding of 2,032 shares of common stock for tax obligations related to restricted stock unit vesting.

Progyny's EVP and General Counsel, Allison Swartz, reported the sale of common stock and shares withheld for taxes, both executed under a pre-arranged trading plan.

Progyny Director Kevin K. Gordon reported the sale of 2,500 shares of common stock at $22.035 per share under a pre-arranged trading plan.

Progyny, Inc. Executive Chairman David J. Schlanger reported the disposition of 1,893 shares of common stock on July 1, 2025, for tax withholding purposes related to restricted stock unit vesting.

Progyny, Inc. CEO Peter Anevski reported the disposition of 7,977 shares of common stock at $22 per share on July 1, 2025, related to tax withholding upon restricted stock unit vesting.